Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Joaquin Mosquera"'
Autor:
Mariona Riudavets, Joaquin Mosquera, Rosario Garcia-Campelo, Jorgina Serra, Georgia Anguera, Pablo Gallardo, Ivana Sullivan, Andrés Barba, Luís del Carpio, Agustí Barnadas, Ignasi Gich, Margarita Majem
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Immune-related adverse events (irAEs) have been associated with improved efficacy in advanced non-small cell lung cancer (NSCLC) patients receiving anti-PD-(L)1 blockade agents, while the concurrent use of corticosteroids seems to worsen
Externí odkaz:
https://doaj.org/article/96520e3d276046faa5ee81e2ad2674e2
Autor:
Acea-Nebril, Benigno, García-Novoa, Alejandra, Díaz, Mónica Torres, Alejandro, Alberto Bouzón, Carballada, Carlota Díaz, Conde Iglesias, Carmen, Díaz Martínez, Inmaculada, Martínez Arribas, Carme, Calvo Martínez, Lourdes, Novoa, Silvia Antolin, Santiago Freijanes, Paz, Oses, Joaquín Mosquera
Publikováno v:
In Cirugía Española (English Edition) February 2023 101(2):97-106
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Laurence Bigay-Game, Miguel Sampayo, Nicolas Girard, Laurent Greillier, Benjamin Besse, Javier de Castro, Jordi Remon, Sophie Cousin, R. Bernabé, Oscar Juan, Joaquin Mosquera, Silvia Novello
Publikováno v:
CLINICAL LUNG CANCER
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Clinical Lung Cancer
Clinical Lung Cancer, 2021, ⟨10.1016/j.cllc.2021.07.008⟩
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Clinical Lung Cancer
Clinical Lung Cancer, 2021, ⟨10.1016/j.cllc.2021.07.008⟩
International audience; Thymic epithelial tumors are rare neoplastic proliferations of thymic epithelial cells. The aggressiveness of these malignancies increases as higher is the histologic subtype, being thymic carcinoma the most aggressive subtype
Autor:
Ignacio I Wistuba, Amelia Insa, Mariano Provencio, Bartomeu Massutí, Federico Garrido, Edwin R Parra, Delvys Rodriguez-Abreu, Manuel Cobo, Joaquín Casal-Rubio, Ernest Nadal, Javier Martín-López, Diego Megías, Belén Sierra-Rodero, Alberto Cruz-Bermúdez, Alex Martinez-Marti, Isidoro Barneto Aranda, Santiago Viteri, Marta Casarrubios, Cristina Martinez-Toledo, Virginia Calvo, Marta Molina-Alejandre, Francisco Perea, Javier de Castro, Joaquín Mosquera Martínez, Rafael Muñoz-Viana, Natalia Aptsiauri, Francisco Ruiz-Cabello
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 10 (2024)
Background Loss of human leukocyte antigen (HLA) class I expression and loss of heterozygosity (LOH) are common events implicated in the primary resistance of non-small cell lung cancer (NSCLC) to immunotherapy. However, there is no data on periopera
Externí odkaz:
https://doaj.org/article/8c3f29b6cb394ac3ba9e2fc1ab852402
Autor:
Mariona Riudavets, Edouard Auclin, Miguel Mosteiro, Naomi Dempsey, Margarita Majem, Arsela Prelaj, Rafael López-Castro, Joaquim Bosch-Barrera, Sara Pilotto, Elena Escalera, Marco Tagliamento, Joaquin Mosquera, Gerard Zalcman, Frank Aboubakar Nana, Santiago Ponce, Alessandro Dal Maso, Martina Spotti, Xavier Mielgo-Rubio, Elodie Mussat, Roxana Reyes, Jose-Carlos Benítez, Lorena Lupinacci, Boris Duchemann, Andrea De Giglio, Juan Bautista Blaquier, Clarisse Audigier-Valette, Matthias Scheffler, Ernest Nadal, Gilberto de Lima Lopes, Diego Signorelli, Rosario Garcia-Campelo, Jessica Menis, Virginia Bluthgen, Marc Campayo, Gonzalo Recondo, Benjamin Besse, Laura Mezquita, David Planchard
Publikováno v:
SSRN Electronic Journal.
Autor:
Marina Rodríguez-Candela Mateos, Maria Azmat, Paz Santiago-Freijanes, Eva María Galán-Moya, Manuel Fernández-Delgado, Rosa Barbella Aponte, Joaquín Mosquera, Benigno Acea, Eva Cernadas, María D. Mayán
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-19 (2024)
Abstract Breast cancer is the most diagnosed cancer worldwide and represents the fifth cause of cancer mortality globally. It is a highly heterogeneous disease, that comprises various molecular subtypes, often diagnosed by immunohistochemistry. This
Externí odkaz:
https://doaj.org/article/231a556edeec4e41961f4e706f43b3cc
Autor:
Natalia Fernández Núñez, Martin Lázaro Quintela, Iria Carou Frieiro, Joaquin Mosquera Martinez, Margarita Amenedo Gancedo, Joaquin Casal Rubio, Jose Muñoz Iglesias, Alexandra Sabela Cortegoso mosquera, Rocio Vilchez Simo, Urbano Anido Herranz, Jesús García Mata, Lucía Santomé Couto, Begoña Campos Balea, Mª Carmen Areses Manrique, Jorge García González, Mª Rosario García Campelo, Guillermo Alonso-Jaudenes Curbera, José Luis Fírvida Pérez, Cristina Azpitarte Raposeiras, F.J. Afonso
Publikováno v:
Translational Lung Cancer Research. 7:404-415
Background Recently, immunotherapy has changed the standard of treatment in non-small cell lung cancer (NSCLC). Outside clinical trials, data of real life is lacking. This is an observational study that represents the real world experience with nivol
Autor:
Urbano Anido Herranz, Marinha Costa, Joaquin Mosquera Martinez, Rosario Garcia Campelo, Jorge Garcia, Begoña Campos, Susana Gómez, Francisco J. Afonso-Afonso, Francisco Baron, Rocio Vilchez Simo, Natalia Fernandez, Margarita Amenedo, Jesús García Mata, MC Areses, María del Mar Andrés Vázquez, José Luis Fírvida, Guillermo Alonso-Jaudenes Curvera
Publikováno v:
Journal of Thoracic Oncology. 12:S1339-S1340
Autor:
Campelo, Rosario García, Areses, Maria Carmen, Baron, Francisco, Afonso-Afonso, Francisco, Costa, Marinha, Fernandez, Natalia, Amenedo, Margarita, Alonso-Jaudenes Curvera, Guillermo, Vázquez, Maria, Simo, Rocio Vilchez, Martinez, Joaquin Mosquera, Garcia, Jorge, Gómez, Susana, Campos, Begoña, Mata, Jesus Garcia, Herranz, Urbano Anido, Fírvida, Jose Luis
Publikováno v:
In Journal of Thoracic Oncology January 2017 12(1) Supplement:S1339-S1340